News
Important Only
Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses With Allo-316 In Heavily Pretreated Advanced Renal Cell Carcinoma At ASCO
June 1 (Reuters) - Allogene Therapeutics Inc ALLO.O:ALLOGENE THERAPEUTICS PROVIDES UPDATED PHASE 1 DATA HIGHLIGHTING DURABLE RESPONSES WITH ALLO-316 IN HEAVILY PRETREATED ADVANCED RENAL CELL CARCINOMA AT ASCOALLOGENE THERAPEUTICS INC - SINGLE DOSE OF ALLO-316 ACHIEVES 31% RESPONSE RATEReuters
Sun, Jun 1
Arcus Says Initial Data From The Arc-20 Study Of Casdatifan Plus Cabozantinib Showed Nearly Half Of Patients With Metastatic Kidney Cancer Had A Confirmed Response
June 1 (Reuters) - Arcus Biosciences Inc RCUS.N:INITIAL DATA FROM THE ARC-20 STUDY OF CASDATIFAN PLUS CABOZANTINIB SHOWED NEARLY HALF OF PATIENTS WITH METASTATIC KIDNEY CANCER HAD A CONFIRMED RESPONSEARCUS BIOSCIENCES INC - ARC-20 STUDY SHOWS 46% RESPONSE RATE IN METASTATIC KIDNEY CANCERReuters
Sun, Jun 1
EXCLUSIVE-Air India in talks for major new narrow-body jet order, sources say
Air India eyes major expansion of fleet plans, sources sayCarrier looks at large new narrow-body jet order, sources sayBoeing takes lead in talks for large wide-body jets, sources sayBy Tim Hepher, Aditi Shah and Rajesh Kumar Singh NEW DELHI, June 1 (Reuters) - Tata Group's Air India is in ta...Reuters
Sun, Jun 1
Emirates airline boss sees positive progress at troubled Boeing
Emirates president says seeing greater determination from Boeing to resolve its many issuesBoeing trying to stabilize after quality crisis and labour strikeBy Tim Hepher, Nandan Mandayam and Shivansh Tiwary NEW DELHI, June 1 (Reuters) - The head of the world's largest international airline, D...Reuters
Sun, Jun 1
Tennis-Paul misses Florida fishing season but reels in a lunker in Paris
By Karolos Grohmann PARIS, June 1 (Reuters) - Tommy Paul's rods may be gathering dust back home in Florida with the prime fishing season under way but the 12th-seed reeled in one of his biggest catches when he blasted past Australia's Alexei Popyrin in the French Open fourth round on Sund...Reuters
Sun, Jun 1
Ukrainian, Russian delegations to meet in Istanbul at 1000 GMT on Monday, Turkish source says
ANKARA, June 1 (Reuters) - A meeting between Russian and Ukrainian delegations in Istanbul aimed at paving the way for a potential ceasefire is expected to take place at 1000 GMT, or 1 p.m. local time, at the Ciragan Palace, a Turkish Foreign Ministry source said on Sunday.Reuters
Sun, Jun 1
Replimune Presents New Analyses From The IGNYTE Study Of RP1 Plus Nivolumab In Anti-PD1 Failed Melanoma At The 2025 American Society Of Clinical Oncology (ASCO) Annual Meeting
June 1 (Reuters) - Replimune Group Inc REPL.O:REPLIMUNE PRESENTS NEW ANALYSES FROM THE IGNYTE STUDY OF RP1 PLUS NIVOLUMAB IN ANTI-PD1 FAILED MELANOMA AT THE 2025 AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETINGREPLIMUNE GROUP INC - RP1 PLUS NIVOLUMAB SHOWS ROBUST RESPONSES IN INJECTED AND...Reuters
Sun, Jun 1
Soccer-Man United agree deal for Wolves' Brazil forward Cunha
June 1 (Reuters) - Manchester United have agreed a deal to sign Matheus Cunha from Wolverhampton Wanderers, the two Premier League clubs said on Sunday, with the Brazil forward joining on a five-year contract. United triggered the 26-year-old's release clause, which was worth around 62.5 mill...Reuters
Sun, Jun 1
CORRECTED-Soccer-Man United agree deal for Wolves' Brazil forward Cunha
June 1 (Reuters) - Manchester United have agreed a deal to sign Matheus Cunha from Wolverhampton Wanderers, the two Premier League clubs said on Sunday, with the Brazil forward joining on a five-year contract.United triggered the 26-year-old international's release clause, which was worth around...Reuters
Sun, Jun 1
Datroway Continues To Show Promising Tumor Responses As Part Of Combination Regimens In Patients With Early And Advanced Non-Small Cell Lung Cancer
June 1 (Reuters) - Daiichi Sankyo Co Ltd 4568.T:DATROWAY® CONTINUES TO SHOW PROMISING TUMOR RESPONSES AS PART OF COMBINATION REGIMENS IN PATIENTS WITH EARLY AND ADVANCED NON-SMALL CELL LUNG CANCERDAIICHI SANKYO CO LTD - PHASE 2 RESULTS SHOW POTENTIAL FOR DATROWAY PLUS DURVALUMABReuters
Sun, Jun 1
Cullinan Therapeutics Inc - Taiho Oncology And Cullinan Therapeutics Publish Positive Rezilient1 Trial Results
June 1 (Reuters) - Cullinan Therapeutics Inc CGEM.O:CULLINAN THERAPEUTICS INC - TAIHO ONCOLOGY AND CULLINAN THERAPEUTICS PUBLISH POSITIVE REZILIENT1 TRIAL RESULTSCULLINAN THERAPEUTICS INC - REZILIENT1 TRIAL SHOWS 35.2% ORR, 8.8 MONTHS MDORReuters
Sun, Jun 1
Ukraine attacks Russian nuclear-capable bombers in Siberia
Ukraine strikes Russian aircraftBase in Siberia struck, bloggers sayBase in Murmansk region struck, bloggers reportRussia says drones attacked Siberia and Russia's north MOSCOW, June 1 (Reuters) - Ukraine attacked Russian nuclear-capable long-range bombers at a military base in Siberia on Sun...Reuters
Sun, Jun 1
Johnson & Johnson Unveils First-In-Human Results For Pasritamig, Showing Early Anti-Tumor Activity In Prostate Cancer
June 1 (Reuters) - Johnson & Johnson JNJ.N:JOHNSON & JOHNSON UNVEILS FIRST-IN-HUMAN RESULTS FOR PASRITAMIG, SHOWING EARLY ANTI-TUMOR ACTIVITY IN PROSTATE CANCERJOHNSON & JOHNSON - PASRITAMIG SHOWS POTENTIAL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCERJOHNSON & JOHNSON - DATA SH...Reuters
Sun, Jun 1
Saudi Arabia's foreign minister says Israel blocking Ramallah meeting proof of 'extremism'
AMMAN, June 1 (Reuters) - Saudi Arabia's Foreign Minister Prince Faisal bin Farhan Al-Saud said the Israeli government's refusal to allow a delegation of Arab ministers to the occupied West Bank showed its "extremism and rejection of peace".His statements came during a joint press co...Reuters
Sun, Jun 1
Ukraine's Zelenskiy says Ukraine will attend Istanbul talks on Monday
KYIV, June 1 (Reuters) - Ukrainian President Volodymyr Zelenskiy said on Sunday that Ukraine will attend a meeting in Istanbul on Monday proposed by Russia."I outlined (Ukraine's) positions ahead of the meeting in Istanbul on Monday," Zelenskiy wrote on Telegram after meeting with his o...Reuters
Sun, Jun 1
IMFINZI (Durvalumab) Regimen Reduced Risk Of Progression, Recurrence Or Death By 29% In Early-Stage Gastric Cancer Versus Chemotherapy Alone In Matterhorn Phase III Trial
June 1 (Reuters) - AstraZeneca PLC AZN.L:IMFINZI® (DURVALUMAB) REGIMEN REDUCED RISK OF PROGRESSION, RECURRENCE OR DEATH BY 29% IN EARLY-STAGE GASTRIC CANCER VERSUS. CHEMOTHERAPY ALONE IN MATTERHORN PHASE III TRIALReuters
Sun, Jun 1
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Therapy shrank tumors in 62% of patients in small trialResult was not lasting beyond a few months for most patients"We're on the right track," scientist saysBy Julie SteenhuysenCHICAGO, June 1 (Reuters) - A Gilead Sciences-backed therapy made with a patient's own white blood cells sh...Reuters
Sun, Jun 1
EXCLUSIVE-Air India in talks for major new narrow-body jet order, sources say
By Tim Hepher, Aditi Shah and Rajesh Kumar SinghNEW DELHI, June 1 (Reuters) - Tata Group's Air India is in talks with Airbus and Boeing for a major new aircraft order including some 200 extra single-aisle planes, topping up a mammoth deal in 2023 as the former state carrier pursues a multi-billi...Reuters
Sun, Jun 1
Ukraine hits over 40 Russian aircraft with drones, security official says
KYIV, June 1 (Reuters) - Ukraine's domestic security agency, the SBU, conducted a large drone attack on over 40 Russian military aircraft on Sunday, an SBU official told Reuters.The source, speaking on condition of anonymity, said the struck aircraft included Tu-95 and Tu-22 strategic bombers, w...Reuters
Sun, Jun 1
